Schedule 13D ownership disclosure

Zenas Biopharma Inc

Security class unavailable · CUSIP: 98937L105

Event date: 2024-09-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-223899
Form type
SC 13D
Filer
SR ONE CAPITAL MANAGEMENT, LLC
CIK
CIK 1853723
Filed
Sep 23, 2024
Reporting period
Sep 16, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub